Monday, November 1, 1993
WASHINGTON - A delegation of biotech leaders from San Diego,
headed by Gensia Inc. Chairman, President & CEO David Hale, are scheduled
to meet with health care advisor Ira Magaziner at the White House tomorrow to
communicate the industry's opposition to price controls on prescription drugs.
Magaziner invited the San Diego excutives to send a delegation
to Washington to discuss their concerns about the administration's health care
proposal during a teleconference call to the CalBio Summit meeting in San Diego
on Oct. 22.
Joining Hale at the meeting will be Ken Widder, chairman and
CEO of Molecular Biosystems Inc., William Rastetter, president and CEO of IDEC
Pharmaceuticals Corp.; Theodore Roth, executive vice president of Alliance Pharmaceuticals
Corp.; William Hawkins, CEO of IVAC Corp.; William Otterson, director of the
University of California at San Diego Connect Program in Technology & Entrepreneurship;
and a representative of the Biotechnology Industry Organization will attend
the meeting, according to BIO President Carl Feldbaum.
BIO's lobbying campaign on health care reform also is focused
on the other end of Pennsylvania Avenue. BIO has targeted 77 members of Congress
who are most likely to shape health care reform legislation.
Back to 'SWAT'
The lawmakers include the leadership of the House and Senate, and the